Gene · 406902
Papers3,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Potential of MicroRNAs as Non-Invasive Prostate Cancer Biomarkers: A Systematic Literature Review Based on a Machine Learning Approach. | Cancers (Basel) | 2022 | 36358836 | PubTator, text mining | PubMed |
| Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy. | Cancers (Basel) | 2022 | 36358672 | PubTator, text mining | PubMed |
| Circulating microRNA Related to Cardiometabolic Risk Factors for Metabolic Syndrome: A Systematic Review. | Metabolites | 2022 | 36355127 | PubTator, text mining | PubMed |
| Role of microRNA in Endocrine Disruptor-Induced Immunomodulation of Metabolic Health. | Metabolites | 2022 | 36355117 | PubTator, text mining | PubMed |
| Fighting Fire with Fire: Exosomes and Acute Pancreatitis-Associated Acute Lung Injury. | Bioengineering (Basel) | 2022 | 36354526 | PubTator, text mining | PubMed |
| Association between lipid peroxidation biomarkers and microRNA expression profiles. | Redox Biol | 2022 | 36335760 | PubTator, text mining | PubMed |
| Stellate ganglion block relieves acute lung injury induced by severe acute pancreatitis via the miR-155-5p/SOCS5/JAK2/STAT3 axis. | Eur J Med Res | 2022 | 36333771 | PubTator, text mining | PubMed |
| MicroRNA profiling of paediatric AML with FLT-ITD or MLL-rearrangements: Expression signatures and in vitro modulation of miR-221-3p and miR-222-3p with BRD4/HATs inhibitors. | Oncol Rep | 2022 | 36321792 | PubTator, text mining | PubMed |
| The antihyperlipidemic drug potassium piperonate impairs the migration and tumorigenesis of breast cancer cells via the upregulation of miR-31. | Front Oncol | 2022 | 36313626 | PubTator, text mining | PubMed |
| Identifying potential microRNA biomarkers for colon cancer and colorectal cancer through bound nuclear norm regularization. | Front Genet | 2022 | 36313468 | PubTator, text mining | PubMed |
| Serum extracellular vesicle MicroRNAs as candidate biomarkers for acute rejection in patients subjected to liver transplant. | Front Genet | 2022 | 36313425 | PubTator, text mining | PubMed |
| Study of Small Non-Coding RNA (miRNA) Expression Pattern of Fertile/Infertile Male Semen. | Acta Inform Med | 2022 | 36311149 | PubTator, text mining | PubMed |
| Emerging role of lncRNAs in osteoarthritis: An updated review. | Front Immunol | 2022 | 36304464 | PubTator, text mining | PubMed |
| VascuFit: vascular effects of non-linear periodized exercise training in sedentary adults with elevated cardiovascular risk - protocol for a randomized controlled trial. | BMC Cardiovasc Disord | 2022 | 36303113 | PubTator, text mining | PubMed |
| Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. | Cell Death Dis | 2022 | 36302755 | PubTator, text mining | PubMed |
| Mesenchymal stem cells-derived exosomes as a promising new approach for the treatment of infertility caused by polycystic ovary syndrome. | Front Pharmacol | 2022 | 36299896 | PubTator, text mining | PubMed |
| Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. | Pharmaceuticals (Basel) | 2022 | 36297381 | PubTator, text mining | PubMed |
| Phragmanthera austroarabica A.G.Mill. and J.A.Nyberg Triggers Apoptosis in MDA-MB-231 Cells In Vitro and In Vivo Assays: Simultaneous Determination of Selected Constituents. | Metabolites | 2022 | 36295823 | PubTator, text mining | PubMed |
| The Diagnostic and Therapeutic Role of Circular RNA HIPK3 in Human Diseases. | Diagnostics (Basel) | 2022 | 36292157 | PubTator, text mining | PubMed |
| CSMD1 Shows Complex Patterns of Somatic Copy Number Alterations and Expressions of mRNAs and Target Micro RNAs in Esophageal Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36291785 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406902/papers?page=25